Submitted by Anonymous (not verified) on 29 January 2026 - 11:42
Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 38, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 38, Status: Authorised